ALK expression in pseudosarcomatous myofibroblastic proliferations of the genitourinary tract
- 28 March 2006
- journal article
- Published by Wiley in Histopathology
- Vol. 48 (5), 569-578
- https://doi.org/10.1111/j.1365-2559.2006.02376.x
Abstract
Aims : Pseudosarcomatous myofibroblastic proliferation of the genitourinary tract is rare and may develop after trauma or spontaneously. The aim of this study was to characterize further the clinicopathological features of these lesions and to examine their relationship to inflammatory myofibroblastic tumour (IMT). Methods and results : Twenty-seven cases of pseudosarcomatous myofibroblastic proliferation were analysed. There were seven males and 20 females; median age was 37 years (range 16–88). Most lesions were from the bladder (n = 21), while others were in the urethra, vulva, vagina, rectum and retrovesical space. Median tumour size was 30 mm (range 6–120 mm). Seven cases (25%) had a history of prior trauma or surgery. Three cases recurred locally but not destructively. The tumours had fasciitis-like features including bland spindle cells with evenly distributed chromatin, admixed inflammatory cells (mainly lymphocytes) and often a myxoid stroma. Immunohistochemistry showed positivity for smooth muscle actin in 14/20 cases, keratin in 8/19, desmin in 7/20 and anaplastic lymphoma kinase (ALK) in 10/21 cases. Fluorescent in situ hybridization was performed in six ALK+ cases; all were negative for ALK gene rearrangement. Conclusions : Pseudosarcomatous myofibroblastic proliferations of the genitourinary tract may show ALK immunopositivity but do not show consistent ALK rearrangement. Given subtle morphological differences and more consistently benign behaviour, their relationship to inflammatory myofibroblastic tumour at other sites remains uncertain.Keywords
This publication has 34 references indexed in Scilit:
- Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literatureLaboratory Investigation, 2004
- Fusion of ALK to the Ran‐binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumorGenes, Chromosomes and Cancer, 2003
- Expression of ALK1 and p80 in Inflammatory Myofibroblastic Tumor and Its Mesenchymal Mimics: A Study of 135 CasesLaboratory Investigation, 2002
- Inflammatory Pseudotumor and Sarcoma of Urinary Bladder: Differential Diagnosis and Outcome in Thirty-Eight Spindle Cell NeoplasmsLaboratory Investigation, 2001
- Fusion of the ALK Gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory Myofibroblastic TumorThe American Journal of Pathology, 2001
- ALK probe rearrangement in a t(2;11;2)(p23;p15;q31) translocation found in a prenatal myofibroblastic fibrous lesion: Toward a molecular definition of an inflammatory myofibroblastic tumor family?Genes, Chromosomes and Cancer, 2001
- Pseudosarcomatous Myofibroblastic Tumor of the Urinary Bladder in Children– A Study of 11 Cases with Review of the LiteratureThe American Journal of Surgical Pathology, 1995
- Inflammatory pseudotumour of the urinary bladderHistopathology, 1991
- Spindle-Cell Proliferations of the Urinary TractThe American Journal of Surgical Pathology, 1988
- Postoperative spindle cell nodules of genitourinary tract resembling sarcomas A report of eight casesThe American Journal of Surgical Pathology, 1984